These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3337628)

  • 1. Pseudomonas cepacia-associated pneumonia in cystic fibrosis. Relation of clinical features to histopathologic patterns of pneumonia.
    Tomashefski JF; Thomassen MJ; Bruce MC; Goldberg HI; Konstan MW; Stern RC
    Arch Pathol Lab Med; 1988 Feb; 112(2):166-72. PubMed ID: 3337628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia.
    Starke JR; Edwards MS; Langston C; Baker CJ
    Pediatr Res; 1987 Dec; 22(6):698-702. PubMed ID: 3431954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing pseudomonas colonization in cystic fibrosis.
    Kulczycki LL; Wientzen RL; Heller T; Bellanti JA
    Ann Allergy; 1988 May; 60(5):423-8. PubMed ID: 2453130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
    Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
    J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients.
    Nilsson E; Larsson A; Olesen HV; Wejåker PE; Kollberg H
    Pediatr Pulmonol; 2008 Sep; 43(9):892-9. PubMed ID: 18680179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic features of Burkholderia cepacia pneumonia in patients without cystic fibrosis.
    Belchis DA; Simpson E; Colby T
    Mod Pathol; 2000 Apr; 13(4):369-72. PubMed ID: 10786801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relations between the frequency of the DeltaF 508 mutation and the course of pulmonary disease in cystic fibrosis patients infected with Pseudomonas aeruginosa.
    Rosenecker J
    Eur J Med Res; 2000 Aug; 5(8):356-9. PubMed ID: 10958769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.
    Rosenstein BJ; Hall DE
    Johns Hopkins Med J; 1980 Nov; 147(5):188-9. PubMed ID: 7441939
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
    Walsh NM; Casano AA; Manangan LP; Sinkowitz-Cochran RL; Jarvis WR
    J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas (Burkholderia) cepacia in children with cystic fibrosis: epidemiological investigation by analysis or restriction fragment length polymorphism.
    Valcin M; Moissenet D; Sardet A; Tournier G; Garbarg-Chenon A; Vu-Thien H
    Pathol Biol (Paris); 1996 May; 44(5):442-6. PubMed ID: 8758491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
    Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
    Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.
    Thomassen MJ; Demko CA; Klinger JD; Stern RC
    Am Rev Respir Dis; 1985 May; 131(5):791-6. PubMed ID: 3923882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
    Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
    Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of mortality in adults with cystic fibrosis.
    Courtney JM; Bradley J; Mccaughan J; O'Connor TM; Shortt C; Bredin CP; Bradbury I; Elborn JS
    Pediatr Pulmonol; 2007 Jun; 42(6):525-32. PubMed ID: 17469153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome.
    Tablan OC; Chorba TL; Schidlow DV; White JW; Hardy KA; Gilligan PH; Morgan WM; Carson LA; Martone WJ; Jason JM
    J Pediatr; 1985 Sep; 107(3):382-7. PubMed ID: 4032134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.
    Tablan OC; Martone WJ; Doershuk CF; Stern RC; Thomassen MJ; Klinger JD; White JW; Carson LA; Jarvis WR
    Chest; 1987 Apr; 91(4):527-32. PubMed ID: 3829745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.